IFG Advisory’s Insmed INSM Stock Holding History

IFG Advisory’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,750	Closed	-$318K	–	500
2024 Q2	$318K	Buy	+4,750	New	+$184K	0.02%	500

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

IFG Advisory's INSM Position: Q3 2024 in Review

IFG Advisory sold out of Insmed (INSM) in Q3 2024, closing a stake of 4,750 shares — an estimated $318K sold.

IFG Advisory first reported a position in INSM in Q2 2024 and held it in 1 quarter. The position peaked at $318K in Q2 2024. 413 funds tracked by Wall St. Rank hold INSM as of Q3 2024.

IFG Advisory reported no remaining Insmed position as of Q3 2024 after selling out during the quarter.
IFG Advisory sold 4,750 Insmed shares in Q3 2024, an estimated $318K.
IFG Advisory first reported a position in Insmed in Q2 2024 and held it in 1 quarter.
IFG Advisory's Insmed position peaked at $318K in Q2 2024.
413 funds tracked by Wall St. Rank held Insmed as of Q3 2024.

Based on IFG Advisory's 13F filing for Q3 2024, filed 30 Oct 2024.